Vinci Pharmaceuticals, Inc. — Form D
Vinci Pharmaceuticals, Inc. of Avon by the Sea, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2026-01-26. The offering totals $25.3M, of which $20.2M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2026-01-26
- Form: D
- Accession: 0001785495-26-000003
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $25.3M
- Amount sold: $20.2M
- Remaining: $5.1M
- Investors: 53
- Date of first sale: 2026-01-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-571185
Issuer
- Name: Vinci Pharmaceuticals, Inc.
- CIK: 0001785495
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 12 Washington Avenue, Avon by the Sea, NJ, 07717
- Phone: 914-582-8305
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Neil Austrian Jr. | Director | Avon by the Sea, NJ |
| Sarah Hassan | Director | Avon by the Sea, NJ |
| Sigurd Kirk | Director | Avon by the Sea, NJ |
| Richard Lindstrom | Director | Avon by the Sea, NJ |
| Philip Gioia | Director | Avon by the Sea, NJ |
| Philip Gioia | Executive Officer | Avon by the Sea, NJ |
Other filings by this issuer (1)
More